Hosted on MSN1mon
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NASDAQ:NVAX) shares climbed 12% premarket on Monday after the U.S. FDA lifted clinical hold on the investigational new drug application for the pharma firm’s COVID-19-Influenza ...
Axios Vitals on MSN3mon
FDA halts trial of Novavax COVID-flu combo shot
The clinical hold does not impact Novavax's COVID-19 vaccine. The big picture: Pfizer and BioNTech's effort to develop a ...
Nasdaq1mon
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
The study will compare the immunogenicity and safety of the CIC vaccine with separate administrations of Novavax’s ... COVID/flu combination vaccines. Earlier today, SNY announced that the FDA ...
Seeking Alpha8d
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade)
I have been warning about Novavax's risks since 2016, highlighting its ongoing struggles with the FDA. Novavax's Q3 ... Novavax's combination proprietary flu plus COVID combo "very, very soon ...